Technology
Health
Biotechnology

Vaxart

$0.7115
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0015 (0.21%) Today
$0.00 (0.00%) As of 3:58 PM EDT after-hours

Why Robinhood?

You can buy or sell Vaxart and other stocks, options, ETFs, and crypto commission-free!

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. Read More The company was founded in 2004 and is headquartered in South San Francisco, CA.

Employees
34
Headquarters
South San Francisco, California
Founded
2004
Market Cap
5.92M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
121.12K
High Today
$0.73
Low Today
$0.6651
Open Price
$0.712
Volume
81.26K
52 Week High
$7.60
52 Week Low
$0.6049

Collections

Technology
Health
Biotechnology
Medical
US
North America

VXRT Earnings

-$1.24
-$0.89
-$0.53
-$0.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.